May 13th, 2013
Selections from Richard Lehman’s Literature Review: May 13th
Richard Lehman, BM, BCh, MRCGP
This week’s topics include the ADVANCE III trial, the latest fish-oil supplement study, and a review of management strategies for asymptomatic carotid stenosis.
May 9th, 2013
Another Disappointing Study for Fish Oil Supplements
Larry Husten, PHD
Another large study has failed to find any benefits for fish oil supplements. The Italian Risk and Prevention Study, published in the New England Journal of Medicine, enrolled 12,513 people who had not had a myocardial infarction but had evidence of atherosclerosis or had multiple cardiovascular risk factors. The patients were randomized to either a fish oil supplement […]
August 29th, 2010
Alpha Omega Trial Tests Omega-3 Fatty Acids in CV Disease
Larry Husten, PHD
To test the effect of omega-3 fatty acids in cardiovascular disease, Kromhaut and colleagues with the Alpha Omega Trial Group randomized 4837 patients with a history of MI to treatment with one of four margarine preparations: one containing EPA and DHA; one with ALA; one with EPA, DHA, and ALA; or placebo. After 40 months, […]
NEJM Journal Watch — Recent Cardiology Articles- Anticoagulation in Patients with Cancer-Associated Pulmonary Embolism: How Long is Long Enough?
- Spironolactone Use After Percutaneous Intervention for Acute Myocardial Infarction
- CRISPR/Cas9 Gene Editing for Transthyretin Cardiomyopathy
- Does Colchicine Reduce Cardiac Events After Myocardial Infarction?
- First-Line Therapy for Ventricular Tachycardia After MI: What's the Best Approach?